tirzepatide fda approved for weight loss What Is Used for? and Potential Uses FDA confirms tirzepatide shortage is

Neuropharmacol 23, 324330

A team of researchers at the University of Bern, Switzerland, recently reported that the use of the antidiabetic medicine semaglutide is associated with an increased risk of vision impairment

Similarly the weight loss seen with Exenatide and some other early GLP-1 drugs was thought too limited to win approval for the treatment of obesity (Gilbert, Rosenthal, March 2024)

Most reports were submitted by consumers (n = 23,663, 81.7%), with physicians accounting for 8.5% (n = 2,451)

Two studies reported hair loss as an adverse event

It is made by Novo Nordisk, the same company that manufactures Ozempic and uses the same GLP-1 as Ozempic